Factors Affecting Treatment and Recurrence of <i>Clostridium difficile</i> Infections-Reference-Cited by-同舟云学术

Factors Affecting Treatment and Recurrence of Clostridium difficile Infections

Published:2014 Issue:11 Volume:37 Page:1811-1815
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Matsumoto Kazuaki¹²,Kanazawa Naoko¹²,Shigemi Akari¹²,Ikawa Kazuro³,Morikawa Norifumi³,Koriyama Toyoyasu²,Orita Michiyo²,Kawamura Hideki²,Tokuda Koichi²,Nishi Junichiro²,Takeda Yasuo¹

Affiliation:

1. Department of Clinical Pharmacy and Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University

2. Kagoshima University Hospital, Infection Control Team

3. Department of Clinical Pharmacotherapy, Hiroshima University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/37/11/37_b14-00492/_pdf

Reference31 articles.

1. 1) McFarland LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat. Clin. Pract. Gastroenterol. Hepatol., 5, 40–48 (2008).

2. 2) Aldeyab MA, Harbarth S, Vernaz N, Kearney MP, Scott MG, Funston C, Savage K, Kelly D, Aldiab MA, McElnay JC. Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients. Antimicrob. Agents Chemother., 53, 2082–2088 (2009).

3. 3) Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am. J. Gastroenterol., 107, 1001–1010 (2012).

4. 4) Thomas C, Stevenson M, Riley TV. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J. Antimicrob. Chemother., 51, 1339–1350 (2003).

5. 5) Vernaz N, Hill K, Leggeat S, Nathwani D, Philips G, Bonnabry P, Davey P. Temporal effects of antibiotic use and Clostridium difficile infections. J. Antimicrob. Chemother., 63, 1272–1275 (2009).

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Efficacy of Therapeutic Agents for <i>Clostridioides difficile</i> Infection Based on Four Severity Classifications;Japanese Journal of Infectious Diseases;2024-03-29

2. Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection;Journal of Infection and Chemotherapy;2022-08

3. Retrospective study of the efficacy and safety of metronidazole and vancomycin for Clostridioides difficile infection;Journal of Infection and Chemotherapy;2021-10

4. The Trend for Antibiotic Use for Clostridioides (Clostridium) difficile Infection in Japan;Biological and Pharmaceutical Bulletin;2020-04-01

5. Excess length of hospital stay, mortality and cost attributable to Clostridioides (Clostridium) difficile infection and recurrence: a nationwide analysis in Japan;Epidemiology and Infection;2020